Retinal vein occlusion market overview and analysis by type, by condition, diagnosis, treatment, end user - forecast till 2030. The global retinal vein occlusion market is expected to rise at a CAGR of 15.56% over the forecast period, according to the latest research report from Market Research Future (MRFR). The global retinal vein occlusion market is mainly driven by the growing awareness about the disease, the growing prevalence of the disease, including the rising prevalence of diabetes, which is a major risk factor for the disease, and the growing efforts being taken by market players to come up with effective remedies for the disease.
When clots or other blockages develop in the veins that transport blood away from the retina, the condition known as retinal vein occlusion takes place. Blood flow is constrained as a result of the blood cycle's disruption in the particularly delicate area. This could cause vision loss because the region around the corneas and the eyes is particularly sensitive to even the smallest disturbances. Retinal vein blockage is one of the most typical causes of vision loss in the globe. This is predicted to boost the global retinal vein occlusion market at a strong growth rate throughout the course of the forecast year. The rising prevalence of diabetes is also likely to act as a key driver for the global retinal vein occlusion market, as having diabetes considerably increases the risk of getting a retinal vein occlusion.
During the course of the forecast period, the growing consumer attention on ophthalmic care is projected to play a significant role in the expansion of the worldwide retinal vein occlusion market. While ophthalmic care has always been significant, current methods and processes are making it ever more refined and complex, leading to it becoming even more important within the healthcare industry. The retinal vein occlusion market may also be significantly influenced by the growing sophistication of the ophthalmology field, which may result in the development of more cutting-edge, creative treatments for the condition.
Competitive Analysis:
The global retinal vein occlusion market players include Allergan, Bristol-Myers Squibb, Ellex Medical Lasers, IRIDEX Corporation, Quantel Medical Inc., ZEISS, Sanofi Aventis, Alimera Sciences, Icon Biosciences, Genentech Inc., Johnson Johnson Services Inc., Pfizer Inc., Aerpio Therapeutics Inc., Annexin Pharmaceuticals AB, AstraZeneca, Teva Pharmaceutical, Ranbaxy Pharmaceuticals, Suzuken Co. Ltd., Fovea Pharmaceuticals SA, Valeant Pharmaceuticals, Lumenis, Topcon Medical Systems Inc., Novartis, GlaxoSmithKline plc, Regeneron Pharmaceuticals, and Bayer.
Segmentation:
The global retinal vein occlusion market size is segmented on the basis of type, condition, diagnosis, treatment, and end user.
On the basis of type, the retinal vein occlusion market is segmented into branch retinal artery occlusion and central retinal vein occlusion.
On the basis of the condition, the retinal vein occlusion market is segmented into non-ischemic and ischemic. The non-ischemic segment held a majority share of more than 62% in the global retinal vein occlusion market in 2016.
Based on diagnosis, the market is segmented into optical coherence tomography (OCT), fundoscopic examination, fluorescein angiography, and others. Fundoscopic examination is the leading segment of the global retinal vein occlusion market by diagnosis.
On the basis of treatment, the retinal vein occlusion market is segmented into antivascular endothelial growth factor, corticosteroid drugs, laser retinal photocoagulation, and others.
On the basis of end use, it is segmented into hospitals and clinics, research academics centers, and others.
Regional Analysis:
The Americas dominate the global retinal vein occlusion market due to the overall higher level of technology present in the medical establishments in the region, the high disposable income of consumers in the region, and the growing prevalence of retinal vein occlusion in the region. The growing geriatric population in North America and the strong research sector in the region is also a key factor in the growth of the retinal vein occlusion market in the Americas.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
